Samarth Kulkarni
Amministratore Delegato presso CRISPR THERAPEUTICS AG
Patrimonio netto: 22 M $ in data 30/04/2024
Profilo
Samarth Kulkarni è presidente di Casebia Therapeutics LLP. Il Dr. Kulkarni è anche nel consiglio di amministrazione di Black Diamond Therapeutics, Inc., Repare Therapeutics, Inc. e Centessa Pharmaceuticals Ltd., nonché amministratore delegato e direttore di CRISPR Therapeutics AG e direttore della sezione Aziende emergenti di Biotechnology Innovation Organization. In passato Samarth Kulkarni ha ricoperto la posizione di Partner presso McKinsey & Co., Inc. Ha ricevuto un dottorato dall'Università di Washington e una laurea presso l'Indian Institute of Technology New Delhi.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
CRISPR THERAPEUTICS AG
0.48% | 15/04/2024 | 408 122 ( 0.48% ) | 22 M $ | 30/04/2024 |
30/04/2024 | 0 ( -.--% ) | - $ | 30/04/2024 | |
05/04/2024 | 0 ( -.--% ) | - $ | 30/04/2024 | |
REPARE THERAPEUTICS INC.
-.--% | 15/04/2024 | 0 ( -.--% ) | - $ | 30/04/2024 |
Posizioni attive di Samarth Kulkarni
Società | Posizione | Inizio |
---|---|---|
CRISPR THERAPEUTICS AG | Amministratore Delegato | 01/12/2017 |
REPARE THERAPEUTICS INC. | Direttore/Membro del Consiglio | 01/11/2019 |
BLACK DIAMOND THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 01/12/2019 |
CENTESSA PHARMACEUTICALS PLC | Direttore/Membro del Consiglio | 23/02/2021 |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Corporate Officer/Principal | - |
CRISPR Therapeutics, Inc.
CRISPR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of CRISPR Therapeutics AG, CRISPR Therapeutics, Inc. develops gene-based medicines for the treatment of human diseases. The company is based in Cambridge, MA. The CEO of the company is Samarth Kulkarni. | Amministratore Delegato | - |
Precedenti posizioni note di Samarth Kulkarni
Società | Posizione | Fine |
---|---|---|
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/07/2015 |
Casebia Therapeutics LLP
Casebia Therapeutics LLP Miscellaneous Commercial ServicesCommercial Services Casebia Therapeutics LLP provides physical, chemical, and analytical testing services. The British company was founded in 2016, and Jim Burns has been the CEO of the company since 2019. | Presidente | - |
Casebia Therapeutics LLC
Casebia Therapeutics LLC Pharmaceuticals: GenericHealth Technology Casebia Therapeutics LLC is a joint venture company that focuses on discovering, developing, and commercializing gene-editing therapeutics to treat genetic causes of bleeding disorders and autoimmune diseases. The company is based in Cambridge, MA. | Direttore/Membro del Consiglio | - |
Formazione di Samarth Kulkarni
University of Washington | Doctorate Degree |
Indian Institute of Technology New Delhi | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 4 |
---|---|
CRISPR THERAPEUTICS AG | Health Technology |
BLACK DIAMOND THERAPEUTICS, INC. | Health Technology |
REPARE THERAPEUTICS INC. | Health Technology |
CENTESSA PHARMACEUTICALS PLC | Health Technology |
Aziende private | 5 |
---|---|
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Commercial Services |
CRISPR Therapeutics, Inc.
CRISPR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of CRISPR Therapeutics AG, CRISPR Therapeutics, Inc. develops gene-based medicines for the treatment of human diseases. The company is based in Cambridge, MA. The CEO of the company is Samarth Kulkarni. | Health Technology |
Casebia Therapeutics LLC
Casebia Therapeutics LLC Pharmaceuticals: GenericHealth Technology Casebia Therapeutics LLC is a joint venture company that focuses on discovering, developing, and commercializing gene-editing therapeutics to treat genetic causes of bleeding disorders and autoimmune diseases. The company is based in Cambridge, MA. | Health Technology |
Casebia Therapeutics LLP
Casebia Therapeutics LLP Miscellaneous Commercial ServicesCommercial Services Casebia Therapeutics LLP provides physical, chemical, and analytical testing services. The British company was founded in 2016, and Jim Burns has been the CEO of the company since 2019. | Commercial Services |
- Borsa valori
- Insiders
- Samarth Kulkarni